Business Segments Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE Other stock markets 00:00:02 12/06/2026 +04			5-day change	1st Jan Change
292.44 ^USD	+0.49%		-4.89%	-3.48%

06-03	Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM
05-19	Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 08:30 AM

Breakdown by Business Segment (USD)

Fiscal Period: December	2021	2022	2023	2024	2025
Medical Testing, Analyzing, and Diagnostic Equipment
Clinical Diagnostics	1.52B	1.45B	1.49B	1.54B	1.56B
Total Assets	1.04B	449M	493M	473M	451M
Interest Expense	-1M	-	-	-	-
CAPEX	-63.5M	-	-	-	-
EBT	173M	-	-	-	-
Gross Profit	-	-	-	797M	787M
D&A	61.1M	79.4M	83.1M	84.3M	90.4M
Operating Income	-	218M	230M	-	-
Life Sciences Tools and Services
Life Science	1.4B	1.35B	1.18B	1.03B	1.02B
Total Assets	588M	270M	287M	287M	289M
Interest Expense	-600K	-	-	-	-
CAPEX	-12.8M	-	-	-	-
EBT	316M	-	-	-	-
Gross Profit	-	-	-	582M	553M
D&A	32.5M	57.9M	62.8M	67.3M	75M
Operating Income	-	267M	109M	-	-
Other Operations	5.8M	4M	3.6M	500K	-
Total Assets	16.8M	600K	300K	-	-
Interest Expense	-	-	-	-	-
CAPEX	-7.6M	-	-	-	-
EBT	-1.1M	-	-	-	-
Gross Profit	-	-	-	-100K	-
D&A	1.6M	-	-	-	-
Operating Income	-	-1.9M	-700K	-	-
EBT	4.93B	-	-	-	-
Total Assets	347M	-	-	410M	580M
Total Assets	14.74B	-	-	5.23B	6.38B
Total Assets	48.2M	-	-	689M	710M
Total Assets	993M	-	-	2.27B	2.17B
EBT	26.8M	-	-	-	-
EBT	-	-	-	-	-
EBT	-2.8M	-	-	-	-

Geographical breakdown of sales (USD)

Fiscal Period: December	2021	2022	2023	2024	2025
United States	1.13B	1.16B	1.12B	1.04B	1.02B
Total Assets	456M	466M	477M	461M	470M
Europe	947M	852M	820M	834M	882M
Total Assets	211M	184M	197M	171M	188M
Asia	688M	639M	563M	522M	513M
Total Assets	64.9M	63.8M	82.7M	97.1M	93.3M
Other (primarily Canada and Latin America)	157M	155M	167M	169M	165M
Total Assets	16.5M	15.6M	19.1M	14.1M	16.7M
Pacific Rim	-	-	-	-	-
Total Assets	-	-	-	-	-